Urogynecology · Menopause
Vulvar atrophy: treatment that actually reverses it
Vulvar and vaginal atrophy is the tissue-level manifestation of GSM: thinning, loss of elasticity, decreased blood flow, altered pH, and shrinkage of the labia and vaginal canal. It doesn't get better with time — but it responds beautifully to local estrogen or DHEA within 8–12 weeks.
What atrophy looks and feels like
- Vulvar and vaginal dryness, itching, burning
- Thinning of the labia minora
- Introital narrowing (making penetration painful)
- Pale, smooth, or shiny vulvar skin
- Loss of elasticity and shrinkage
- Increased pH and susceptibility to UTIs
Treatment ladder
- Estradiol vaginal cream (Estrace) 0.5–1g 2×/week
- Vaginal tablets (Vagifem, Yuvafem) 2×/week
- Vaginal ring (Estring) — replace every 90 days
- Prasterone (Intrarosa) — vaginal DHEA nightly
- Non-hormonal moisturizers as adjunct
Frequently asked questions
What causes vulvar atrophy?
Estrogen loss. Vulvar and vaginal tissue is highly estrogen-dependent — without it, epithelium thins, collagen decreases, and blood flow drops.
Is vulvar atrophy the same as lichen sclerosus?
No. Lichen sclerosus is autoimmune, has white patchy plaques, and requires clobetasol. Vulvar atrophy is hormonal. A dermatologist or gyn can differentiate.
What is the first-line treatment?
Topical vaginal estrogen (cream, tablet, or ring) applied 2–3× weekly. Vaginal DHEA (prasterone) is an alternative.
Do I need to keep using it forever?
Yes — stopping brings symptoms back within 3–6 months. It is a chronic condition requiring chronic treatment.
Is it safe long-term?
Yes. Systemic absorption is minimal, endometrial safety is well-established, and cancer risk is not increased.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.